Peter S. Klein
Independent DirectorMr. Peter S. Klein is Chief Financial Officer of William Morris Endeavor Entertainment, LLC. He joined the William Morris Endeavor Entertainment, LLC on December 23, 2013. He is Independent Director of Denali Therapeutics Inc. from March 16, 2018. He joined the Denali Therapeutics Inc. on March 16, 2018. He was Independent Director of Joshua Green Corporation. He was Independent Director of F5, Inc. from March 12, 2015 to 2025. He was employed at F5, Inc. from March 12, 2015 to 2025. He was Director of Apptio, Inc. from November 2013 to 2019. He was employed at Apptio, Inc. from November 2013 to 2019. He was Chief Financial Officer of Asta Networks. He was Independent Director of Palladyne AI Corp. from October 2016 to 2024. He was employed at Palladyne AI Corp. from May 07, 2015 to 2024. He was Lead Independent Director of Accolade, Inc. from June 2021 to April 8 , 2025. He was Independent Director of Accolade, Inc. from September 2019 to June 2021. He was employed at Accolade, Inc. from September 2019 to April 8 , 2025. He has M.B.A. from University of Washington, B.A. in History from Yale University.
Positions
- Company NameDenali Therapeutics Inc.Stock CodeDNLIPositionIndependent DirectorColleagues
- RJRyan J. WattsCo-Founder, President, CEO & Director
- JCJulian Charles BakerIndependent Chairperson
- AOAlexander O. SchuthCo-Founder, CFO, COO & Secretary
- DADana AndersenChief Technical and Manufacturing Officer
- JLJoe LewcockChief Scientific Officer
- CWChris WalshGeneral Counsel
- JTJay T. FlatleyIndependent Director
- JEJennifer E. CookIndependent Director
